Pacira | PCRX - Créances Commerciales





Créances Commerciales Changement Date
Astellas Pharma JPY 761.76B 48.47B 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 21.33B 3.72B 2025-12
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novo Nordisk DKK 106.26B 11.21B 2026-03
Omeros USD 8.08M 440K 2024-06
Pacira USD 125.64M 1.57M 2026-03
Perrigo USD 697.1M 84.3M 2026-03
Pfizer USD 16.17B 332M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
Xeris Pharmaceuticals USD 56.29M 5.24M 2026-03
Xoma USD 14.78M 4.96M 2024-06
Zoetis USD 1.51B 84M 2026-03